Perturbations in calcium-mediated signal transduction in microglia from Alzheimer's disease patients

J Neurosci Res. 2005 Aug 1;81(3):426-35. doi: 10.1002/jnr.20487.

Abstract

Calcium-sensitive fluorescence microscopy has been used to study Ca2+-dependent signal transduction pathways in microglia obtained from Alzheimer's disease (AD) patients and non-demented (ND) individuals. Data were obtained from nine AD cases and seven ND individuals and included basal levels of intracellular Ca2+ [Ca2+]i, peak amplitudes (Delta[Ca2+]i) and time courses of adenosine triphosphate (ATP) responses and amplitudes of an initial transient response and a subsequent second component of Ca2+ influx through store-operated channels (SOC) induced by platelet-activating factor (PAF). Overall, AD microglia were characterized by significantly higher (20%) basal Ca2+ [Ca2+]i relative to ND cells. The Delta[Ca2+]i of ATP and initial phase of PAF responses, which reflect rapid depletion of Ca2+ from endoplasmic reticulum stores, were reduced by respective values of 63% and 59% in AD cells relative to amplitudes recorded from ND microglia. Additionally, AD microglia showed diminished amplitudes (reduction of 61%) of SOC-mediated Ca2+ entry induced by PAF and prolonged time courses (increase of 60%) of ATP responses with respect to ND microglia. We have generally replicated these results with exposure of human fetal microglia to beta amyloid (5 microM Abeta1-42 applied for 24 hr). Overall, these data indicate significant abnormalities are present in Ca2+-mediated signal transduction in microglia isolated from AD patients.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphate / pharmacology
  • Alzheimer Disease / pathology*
  • Amyloid beta-Peptides / pharmacology
  • Analysis of Variance
  • Calcium / metabolism*
  • Cells, Cultured
  • Drug Interactions
  • Fetus
  • Humans
  • Microglia / drug effects
  • Microglia / metabolism*
  • Microglia / pathology
  • Peptide Fragments / pharmacology
  • Platelet Activating Factor / pharmacology
  • Postmortem Changes
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Spectrometry, Fluorescence / methods

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Platelet Activating Factor
  • amyloid beta-protein (1-42)
  • Adenosine Triphosphate
  • Calcium